Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk? CETP Inhibition as a Strategy to Reduce Cardiovascular Risk: The Pro Case

Philip J. Barter; Stephen J. Nicholls; John J. P. Kastelein; Kerry-Anne Rye

doi:https://doi.org/10.1161/CIRCULATIONAHA.114.014025

Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk? CETP Inhibition as a Strategy to Reduce Cardiovascular Risk: The Pro Case

Philip J. Barter, Stephen J. Nicholls, John J. P. Kastelein, Kerry-Anne Rye

Research output: Contribution to journal › Article › Academic › peer-review

23 Citations (Scopus)

Original language	English
Pages (from-to)	423-432
Journal	Circulation
Volume	132
Issue number	5
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.114.014025
Publication status	Published - 2015

Access to Document

https://doi.org/10.1161/CIRCULATIONAHA.114.014025

Cite this

@article{a34ca774d69f4ccb8e2d44619e2e3f81,

title = "Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk? CETP Inhibition as a Strategy to Reduce Cardiovascular Risk: The Pro Case",

author = "Barter, {Philip J.} and Nicholls, {Stephen J.} and Kastelein, {John J. P.} and Kerry-Anne Rye",

year = "2015",

doi = "https://doi.org/10.1161/CIRCULATIONAHA.114.014025",

language = "English",

volume = "132",

pages = "423--432",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "5",

}

Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk? CETP Inhibition as a Strategy to Reduce Cardiovascular Risk: The Pro Case. / Barter, Philip J.; Nicholls, Stephen J.; Kastelein, John J. P. et al.
In: Circulation, Vol. 132, No. 5, 2015, p. 423-432.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk? CETP Inhibition as a Strategy to Reduce Cardiovascular Risk: The Pro Case

AU - Barter, Philip J.

AU - Nicholls, Stephen J.

AU - Kastelein, John J. P.

AU - Rye, Kerry-Anne

PY - 2015

Y1 - 2015

U2 - https://doi.org/10.1161/CIRCULATIONAHA.114.014025

DO - https://doi.org/10.1161/CIRCULATIONAHA.114.014025

M3 - Article

C2 - 26240263

SN - 0009-7322

VL - 132

SP - 423

EP - 432

JO - Circulation

JF - Circulation

IS - 5

ER -